EVALUATION OF THE MICRODILUTION METHOD FOR DETERMINATION OF THE MINIMUM INHIBITORY CONCENTRATION (MIC) OF TERBINAFINE AGAINST TRICHOPHYTON RUBRUM
Published:
2026-05-30Downloads
Abstract
Trichophyton rubrum is the leading cause of dermatophytosis with a global prevalence of 50–90%. Terbinafine is a first-line therapy that works by inhibiting the squalene epoxidase enzyme in ergosterol biosynthesis. Accurate determination of the minimum inhibitory concentration (MIC) using a standardized susceptibility test method is necessary to ensure the effectiveness of therapy. This study aims to standardize the concentration of terbinafine using the microdilution method based on CLSI M38-A2 guidelines against Trichophyton rubrum ATCC MYA-4438. The test was carried out using an inoculum concentration of 1×10³–3×10³ CFU/mL with varying terbinafine concentrations , then incubated at 28–30°C for 3–4 days. The results showed MIC values of 0.125 µg/mL; 0.25 µg/mL; and 0.125 µg/mL, respectively. An essential agreement (EA) value of 100% indicates high method precision. Morphological analysis revealed changes in hyphal structure in the form of fragmentation, a decrease in the number of conidia, cytoplasmic clumping, and uneven cell walls due to squalene accumulation. Thus, the microdilution method proved valid and reproducible for determining the MIC of terbinafine against T. rubrum .
Keywords:
Trichophyton rubrum terbinafine microdilution MIC antifungal susceptibility testingReferences
1. Deng R, Wang X, Li R. Dermatophyte infection: from fungal pathogenicity to host immune responses. Front Immunol. 2023;14:1285887. doi:10.3389/fimmu.2023.1285887 PubMed PMID: 38022599; PubMed Central PMCID: PMC10652793.
2. Sagut P, Elston DM. Dermatophytosis. J Am Acad Dermatol. 2025;92(1):194–200. doi:10.1016/j.jaad.2024.08.080 PubMed PMID: 39343305.
3. MSD Manual Professional Edition [Internet]. [dikutip 4 Mei 2026]. Overview of Dermatophytoses - Dermatology. Tersedia pada: https://www.msdmanuals.com/professional/dermatologic-disorders/fungal-skin-infections/overview-of-dermatophytoses
4. Jartarkar S, Patil A, Goldust Y, Cockerell C, Schwartz R, Grabbe S, dkk. Pathogenesis, Immunology and Management of Dermatophytosis. J Fungi. 2021;8:39. doi:10.3390/jof8010039
5. Blutfield MS, Lohre JM, Pawich DA, Vlahovic TC. The Immunologic Response to Trichophyton Rubrum in Lower Extremity Fungal Infections. J Fungi. 2015;1(2):130–7. doi:10.3390/jof1020130 PubMed PMID: 29376904; PubMed Central PMCID: PMC5753105.
6. Gupta AK, Susmita, Nguyen HC, Liddy A, Economopoulos V, Wang T. Terbinafine Resistance in Trichophyton rubrum and Trichophyton indotineae: A Literature Review. Antibiotics. 2025;14(5):472. doi:10.3390/antibiotics14050472 PubMed PMID: 40426539; PubMed Central PMCID: PMC12108360.
7. Gaurav V, Bhattacharya SN, Sharma N, Datt S, Kumar P, Rai G, dkk. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy. J Med Mycol. 2021;31(1):101087. doi:10.1016/j.mycmed.2020.101087
8. Kruithoff C, Gamal A, McCormick TS, Ghannoum MA. Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal Resistance. Life. 2023;14(1):1. doi:10.3390/life14010001 PubMed PMID: 38276250; PubMed Central PMCID: PMC10817648.
9. Cañete-Gibas CF, Mele J, Patterson HP, Sanders CJ, Ferrer D, Garcia V, dkk. Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America. J Clin Microbiol. 2023;61(8):e00562-23. doi:10.1128/jcm.00562-23
10. (PDF) Terbinafine Preferred Antifungal with a Focus on Dermatophytes (A Review). ResearchGate. doi:10.31080/ASMI.2020.03.0640
11. Rex JH, Alexander BD, Andes D, Steven D. CLSI M38-A2 Refrence Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard Second Edition. Vol. 2. (CLSI M38-A2; no. M38-A2).
12. Wang HC, Hsieh MI, Choi PC, Wu CJ. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species. J Clin Microbiol. 2018;56(10):e00780-18. doi:10.1128/JCM.00780-18 PubMed PMID: 30093391; PubMed Central PMCID: PMC6156308.
13. Dannaoui E, Espinel-Ingroff A. Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review. J Fungi. 2019;5(4):108. doi:10.3390/jof5040108 PubMed PMID: 31766762; PubMed Central PMCID: PMC6958406.
14. CLSI-M52. Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing System. 1st ed. August 2015.
15. Karumuri S, Singh PK, Shukla P. In Silico Analog Design for Terbinafine Against Trichophyton rubrum: A Preliminary Study. Indian J Microbiol. 2015;55(3):333–40. doi:10.1007/s12088-015-0524-x PubMed PMID: 26063944; PubMed Central PMCID: PMC4456508.
16. Panday M, Pandey D, Upadhyay P, Upadhyay S. Terbinafine Preferred Antifungal with a Focus on Dermatophytes (A Review). Acta Sci Microbiol. 2020;3(7):65–72. doi:10.31080/ASMI.2020.03.0640
17. Kaul S, Yadav S, Dogra S. Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women. Indian Dermatol Online J. 2017;8(5):310–8. doi:10.4103/idoj.IDOJ_169_17 PubMed PMID: 28979861; PubMed Central PMCID: PMC5621188.
18. Ghannoum M, Isham N, Henry W, Kroon H, Yurdakul S. Evaluation of the Morphological Effects of TDT 067 (Terbinafine in Transfersome) and Conventional Terbinafine on Dermatophyte Hyphae In Vitro and In Vivo. Antimicrob Agents Chemother. 2012;56:2530–4. doi:10.1128/AAC.05998-11
19. Sardana K, Gupta A. Rational for Drug Dosimetry and Duration of Terbinafine in the Context of Recalcitrant Dermatophytosis: Is 500 mg Better than 250 mg OD or BD? Indian J Dermatol. 2017;62(6):665–7. doi:10.4103/ijd.IJD_435_17 PubMed PMID: 29263545; PubMed Central PMCID: PMC5724319.
20. Yue X, Li Q, Wang H, Sun Y, Wang A, Zhang Q, dkk. An ultrastructural study of Trichophyton rubrum induced onychomycosis. BMC Infect Dis. 2015;15(1):532. doi:10.1186/s12879-015-1240-1
21. Osborne CS, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS. Biological, Biochemical, and Molecular Characterization of a New Clinical Trichophyton rubrum Isolate Resistant to Terbinafine. Antimicrob Agents Chemother. 2006;50(6):2234–6. doi:10.1128/AAC.01600-05 PubMed PMID: 16723593; PubMed Central PMCID: PMC1479141.
22. Ryder N s. Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(s39):2–7. doi:10.1111/j.1365-2133.1992.tb00001.x
23. Pfaller MA, Diekema DJ. Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012. J Clin Microbiol. 2012;50(9):2846–56. doi:10.1128/jcm.00937-12
License
Copyright (c) 2026 Thalia Anggrea Noor, Delly Chipta Lestari, Conny Riana Tjampakasari
This work is licensed under a Creative Commons Attribution 4.0 International License.
